Distribution analysis of nonsynonymous polymorphisms within the human kinase gene family  by Torkamani, Ali & Schork, Nicholas J.
07) 49–58
www.elsevier.com/locate/ygenoGenomics 90 (20Distribution analysis of nonsynonymous polymorphisms
within the human kinase gene family
Ali Torkamani a, Nicholas J. Schork b,⁎
a Graduate Program in Biomedical Sciences, Department of Medicine, University of California at San Diego, La Jolla, CA 92093, USA
b Department of Psychiatry and Department of Family and Preventive Medicine, Center for Human Genetics and Genomics, Moores UCSD Cancer Center,
California Institute of Telecommunications and Information Technology, Stein Institute for Research on Aging,
University of California at San Diego, La Jolla, CA 92093, USA
Received 28 November 2006; accepted 10 March 2007
Available online 11 May 2007Abstract
The human kinase gene family is composed of 518 genes that are involved in a diverse spectrum of physiological functions. They are also
implicated in a number of diseases and encompass 10% of current drug targets. Contemporary, high-throughput sequencing efforts have identified
a rich source of naturally occurring single nucleotide polymorphisms (SNPs) in kinases, a subset of which occur in the coding region of genes
(cSNPs) and result in a change in the encoded amino acid sequence (nonsynonymous coding SNP; nscSNPs). What fraction of this naturally
occurring variation underlies human disease is largely unknown (uDC), and much of it is assumed not to be disease causing (DC). We pursued a
comprehensive computational analysis of the distribution of 1463 nscSNPs and 999 DC nscSNPs within the kinase gene family and have found
that DCs are overrepresentated in the kinase catalytic domain and in receptor structures. In addition, the frequencies with which specific amino
acid changes occur differ between the DCs and the uDCs, implying different biological characteristics for the two sets of human polymorphisms.
Our results provide insights into the sequence and structural phenomena associated with naturally occurring kinase nscSNPs that contribute to
human diseases.
© 2007 Elsevier Inc. All rights reserved.Keywords: Kinase; Kinases; Disease; Single nucleotide polymorphism; Cancer; Protein domains; Amino acid sequence; Statistical study; BioinformaticsThe human protein kinase family contains 518 members,
which regulate the activity of their substrates through reversible
phosphorylation. As a group, they are involved in extracellular
and intracellular signal transduction [1]. They are also involved
in a number of other cellular processes, including metabolism,
transcriptional regulation, cell cycle and apoptosis regulation,
cytoskeletal rearrangements, and developmental processes [2].
Kinases, except for the atypical kinases, all contain a highly
conserved catalytic core that can be complemented by a number
of different regulatory domains (Fig. 1). These domains are
involved in the determination of a particular kinase's specific set
of substrates through a wide assortment of interactions including
protein–protein, protein–membrane, and protein–carbohydrate
interactions, in addition to kinase localization and response to a⁎ Corresponding author. Fax: +1 858 822 2113.
E-mail address: nschork@ucsd.edu (N.J. Schork).
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doi:10.1016/j.ygeno.2007.03.006variety of signals including calcium, carbohydrates, and peptide
hormones [3]. Alterations in protein kinase signaling play both
fundamental and contributory roles in human disease [4]. In fact,
kinases are the second largest family of current drug targets and
are predicted to be the largest family of putative drug targets at
22% of the druggable genome [5].
An expanding body of literature and genomic databases
consider single nucleotide polymorphisms (SNPs) that alter the
coded amino acid sequence (nonsynonymous coding SNPs);
(nscSNPs) of kinases [4,6–9]. Many of these nscSNPs are
known to cause a distinct and overt disease phenotype and are
classified in this study as “disease causing” (DCs) However, the
majority of these nscSNPs are common and probably “neutral”
variations within the human genome and are not associated with
any overt clinical phenotype. We want to emphasize, however,
that the functional effects of many of these SNPs have not been
explored in full. As a result, we classify them as unknown as to
Fig. 1. Kinase catalytic core image modified from the Protein Kinase Resource
(http://www.kinasenet.org/pkr/Welcome.do). A representative kinase catalytic
core with some conserved motifs highlighted.
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analyzed the distribution of nscSNPs in kinase domains and the
frequency of specific amino acid transitions to predict and
characterize the likely functional effects of nscSNPs in kinases.
In this light, we pursued a number of different analyses that
addressed the properties associated with kinase uDCs and DCs.
These included (1) an analysis of the evolutionary conservation
of the amino acids implicated in kinase nscSNPs as derived
from the Panther database and analysis tools (http://www.
pantherdb.org/), (2) an analysis of the distribution of nscSNPs
(both uDCs and DCs) within different kinase groups, (3) an
analysis of the domain distribution of the SNPs, (4) an analysis
of amino acid distributions, (5) an analysis of amino acid
changes induced by the nscSNPs, (6) an analysis of the
nucleotides implicated in nscSNPs, and (7) a comprehensive
and integrated analysis in which we tried to predict which
groups, domains, etc. and their potential interactions differ-
entiate uDCs from DCs. We also considered the comparison of
mouse kinase SNPs and human kinase SNPs.
Results
SNP identification
Using public sources, we have compiled an extensive record
of nscSNPs in kinases [10–13]. nscSNPs resulting in premature
stop codons were excluded as these represent a rare, special
class of nscSNPS that are very likely to be disease causing. In
total, 999 DCs (41% of total nscSNPs identified) in 52 kinases
and 1463 uDCs (59% of total nscSNPs identified) in 393kinases were cataloged. Most kinases in the DC set had 20 or
fewer DCs, while a few, BTK and RET, had over 100 DCs. All
DCs were from published literature compiled in OMIM [7]
(http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=OMIM),
KinMutBase [4] (http://bioinf.uta.fi/KinMutBase/main_frame.
html), and the Human Gene Mutation Database (HMGD) [9]
(http://www.hgmd.cf.ac.uk/ac/index.php). The DCs that we
identified were associated with a vast spectrum of inherited
diseases including cancers, metabolic disorders, developmental
diseases, and endocrine-related diseases. We obtained uDCs
from dbSNP [6] (http://www.ncbi.nlm.nih.gov/projects/SNP/)
and through the use of the PupaSNP [8] server (http://pupasnp.
bioinfo.ochoa.fib.es/) to compile a list of SNPs that have not
been functionally characterized. The wild-type or major amino
acid was assumed to be the corresponding amino acid from
published sequences in Kinbase (http://kinase.com/human/
kinome/). nscSNP domain distribution was determined by
using InterProScan [14] (http://www.ebi.ac.uk/InterProScan/)
using mainly Prosite [15] and Pfam [16] domain determina-
tions. Domains were then classified into more general
categories including kinase catalytic (kinase; kin), extracellular
receptor (receptor; recp), src homology (SH), pleckstrin
homology (PH), fibronectin (FN), protein–protein interaction
(PPI), protein–membrane interaction (PMI), carbohydrate
binding (CB), immunoglobulin-like (IGL) domains that do
not function as receptors, cytoskeletal interaction (CI), G-
protein and GTPase interaction (GPI), and nucleic acid
interaction (NAI) domains. nscSNPs in domains that did not
clearly belong to one of the following categories were rare and
grouped with nscSNPs outside of any functional domains
(Table 2).
Evolutionary analysis via the panther database
We considered the use of the suite of analysis tools on the
Panther database website to assess the conservation of the
positions of the kinase nscSNPs. Using the substitution
position-specific evolutionary conservation score, “subPSEC”
(http://www.pantherdb.org/tools/csnpScoreForm.jsp), we were
able to differentiate between uDCs (mean=−2.3125±0.04964)
and DCs (mean=−4.1870±0.06830) by the Wilcoxon test
(p<0.0001). The subPSEC score is derived from aligning a
test protein against a library of hidden Markov models
representing distinct protein families. The score is defined
as –| ln(Paij/Pbij) |, where Paij is the probability of observing
amino acid a at position i in HMM j. According to the Panther
website, a score of −3 corresponds to a 50% probability that the
SNP is disease-causing. This result suggests that the DCs in
kinases occupy positions in DNA sequences that are more
highly conserved across species than uDCs in kinases. We
acknowledge that such an analysis has its limitations, since
neighboring amino acids may influence the functional effects of
the amino acid affected by an nscSNP. However, this fact would
tend to bias the results toward the null hypothesis of no
differences between DCs and uDCs; thus our observation of
conservation differences is compelling given the conservative
nature of the analysis.
Table 1
Kinase groups logistic regression
Group Estimate Std. Error χ2 p value
AGC 0.3907 0.1146 11.62 0.0007 a
Atypical 0.2212 0.1072 4.26 0.0391 a
CAMK 0.3162 0.1052 9.03 0.0027 a
CK1 −0.7425 0.4497 2.73 0.0987
CMGC −0.6029 0.2009 9.00 0.0027 a
RGC 1.2574 0.1462 73.94 <.0001 a
STE −1.0929 0.3208 11.61 0.0007 a
TK 1.2513 0.0921 184.55 <.0001 a
TKL 0.9592 0.1028 86.92 <.0001 a
OPK −0.1847 0.1261 2.14 0.1433
a Statistically significant.
Table 2
Kinase domains logistic regression
Domain Estimate Std. Error χ2 p value
Kinase 0.7689 0.0491 244.82 <.0001 a
Receptor 0.8626 0.0944 83.45 <.0001 a
SH 0.7072 0.1876 14.21 0.0002 a
PH 1.4254 0.2247 40.23 <.0001 a
FN −0.6073 0.2366 6.59 0.0103 a
PPI 0.1380 0.1127 1.50 0.2208
PMI 0.0672 0.2940 0.05 0.8190
CB 0.7169 0.2723 6.93 0.0085 a
IGL −0.5612 0.3053 3.38 0.0660
CI −3.5281 9.5550 0.14 0.7119
GPI −3.5281 6.7565 0.27 0.6015
NAI 0.5730 0.2696 4.52 0.0335 a
a Statistically significant.
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A comparison between all DCs and uDCs demonstrated that
their distributions within the different protein kinase groups
were significantly different based on a 10×2 χ2 contingency
table test, p<0.0001). The 10 protein kinase groups for which
we identified DCs and uDCs included the following groups:
protein kinase A, G, and C (AGC); Atypical (AT); calmodulin-
dependent protein kinase (CAMK); casein kinase 1 (CK1); the
cyclin-depdendent, mitogen-activated, glycogen synthase and
CDK-like kinases (CMGC); receptor guanylate cyclase (RGC);
sterile (STE); tyrosine kinases (TK); tyrosine kinase-like
(TKL); and a group that consisted of all other protein kinase
groups (OPK). To determine whether any set of kinase groups
might be predictive of DC status among all the others, we
conducted a binary logistic regression analysis with the DC
status as the dependent variable and the groups associated with
the SNPs as the independent variables [17]. The results of this
analysis suggested that AGC, Atypical, CAMK, STE, RGC,
TK, and TKL were all significant predictors of DC status (Table
1). Univariate analysis using Fisher's exact test also suggested
these associations (data not shown).
It is possible that the extent to which certain kinase groups
have been studied by experimentalists will bias the group
analysis toward enrichment in DCs in the more extensively
studied groups. However, we believe that our analyses do not
suffer from such bias for a few reasons. We note that disease
associations tend to be pursued through a focus on the disease
and then the determination of a mutation more often than the
reverse. To demonstrate that this bias is absent from our
analysis, we compared the group distribution of DCs to the
group distribution of experimentally induced mutations found
in the Swiss-Prot database (10×2 χ2 contingency table test,
p<0.0001) and found that the group distributions are
significantly different. Additionally, there is little or no
correlation between the proportion of experimentally induced
mutations per group and the proportion of disease-causing
mutations per group (R2 =0.08).
Domain analysis
The distribution of all DCs and uDCs with regard to kinase
domains also provided evidence that certain domains were morelikely to harbor DCs based on a 13×2 χ2 contingency table test
(p<0.0001). We also found that the domain distributions of DCs
and uDCs within specific kinase groups were significantly
different for the following groups: AGC (7×2 χ2 contingency
table test, p=0.0008), Atypical (8×2 χ2 contingency table test,
p=0.0103), CAMK (9×2 χ2 contingency table test, p<0.0001),
CMGC (2×2 χ2 contingency table test, p=0.0333), OPK (4×2
χ2 contingency table test, p<0.0226), TK (10×2χ2 contingency
table test, p<0.0001), and TKL (5×2 χ2 contingency table test,
p<0.0001). These combined kinase group and domain analyses
suggest that interactions between specific kinase groups and
domains exist to increase the probability of a disease-related
variation.
We observed that the frequency of DCs vs uDCs was higher
in kinase domains (54% vs 25%), receptor domains (9.11% vs
3.49%), and pleckstrin homology domains (3.30% vs 0.41%).
To test the significance of this observation and determine
whether any domains might be predictive of DC status, we also
conducted a binary logistic regression analysis with DC status
as a dependent variable and the various domains as independent
variables. The results indicated that kinase, receptor, pleckstrin
homology, fibronectin, src homology, nucleic acid interacting,
and carbohydrate binding domains were predictive of DC status
(Table 2). However, when kinase groups were analyzed
separately, the kinase domain remained predictive of DC status
for AGC (p = 0.0005), Atypical (p = 0.0019), CAMK
(p<0.0001), CMGC (p=0.0070), TK and TKL (p<0.0001),
and OPK (p=0.0046) groups, whereas carbohydrate binding
domains were predictive of DC status only for AGC
(p=0.0035) and CAMK (p=0.0027), protein–protein interac-
tion became predictive for CAMK (p=0.0039), receptor
domains remained predictive for RGC (p=0.0269) and TKL
(p<0.0001), and fibronectin domains (p=0.0029) and pleck-
strin homology (p=0.0002) were predictive of DC status when
attention was confined to the TK group.
Amino acid analysis
We considered an analysis comparing the frequencies with
which DCs and uDCs both originate and result in a change to
specific amino acids. We found that DCs and uDCS have
Table 3
Amino acid mutation spectrum logistic regressions
Amino
acid
Initial amino acid nscSNP amino acid
Estimate Std. Error χ2 p value Estimate Std. Error χ2 p value
A −0.2416 0.0832 8.43 0.0037 a −0.3361 0.1119 9.03 0.0027 a
C 0.9026 0.1178 58.64 <.0001 b 0.4556 0.0898 25.74 <.0001 b
D 0.0390 0.0888 0.19 0.6605 0.1106 0.0918 1.45 0.2284
E −0.0662 0.0918 0.52 0.4707 −0.0383 0.1003 0.15 0.7027
F 0.1115 0.1273 0.77 0.3811 0.0268 0.1040 0.07 0.7966
G 0.0929 0.0800 1.34 0.2462 0.0396 0.0884 0.20 0.6541
H −0.1021 0.1214 0.71 0.4008 −0.0596 0.1008 0.35 0.5543
I −0.3474 0.1153 9.08 0.0026 a −0.3481 0.1008 11.93 0.0006 a
K −0.1088 0.1009 1.16 0.2813 −0.0105 0.0927 0.01 0.9097
L −0.01673 0.0825 0.04 0.8395 −0.0806 0.0813 0.98 0.3214
M 0.2836 0.1110 6.52 0.0107 b −0.3722 0.1179 9.97 0.0016 a
N −0.1225 0.1107 1.22 0.2688 −0.1893 0.1084 3.05 0.0809
P −0.1389 0.0822 2.85 0.0914 0.3354 0.0801 17.53 <.0001 b
Q −0.7232 0.1633 19.61 <.0001 a 0.0521 0.0939 0.31 0.5789
R 0.1836 0.0593 9.59 0.0020 b 0.0883 0.0710 1.55 0.2136
S −0.2636 0.0834 9.98 0.0016 a 0.0613 0.0706 0.75 0.3857
T −0.3296 0.1028 10.28 0.0013 a −0.2615 0.0914 8.18 0.0042 a
V −0.2980 0.0849 12.29 0.0005 a −0.3092 0.0893 11.98 0.0005 a
W 0.7967 0.2045 15.18 <.0001 b 0.5986 0.1266 22.34 <.0001 b
Y 0.7100 0.1357 27.36 <.0001 b 0.6502 0.1248 27.16 <.0001 b
a Significant predictor of uDCs.
b Significant predictor of DCs.
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manner (20×2 χ2 contingency table test, p<0.0001). To
determine which amino acids are more likely to be affected by
DCs as opposed to uDCs we complemented the overall 20×2
contingency table analysis with binary logistic regression
analysis and found that transitions from alanine, cysteine,
isoleucine, methoinine, glutamine, arginine, serine, threonine,
valine, trytophan, and tyrosine were significant in determining
DC status (Table 3, left panel).
Analyses investigating the distribution of the amino acid
resulting from the nscSNP (i.e., the transitions to particular
amino acids or the mutant amino acid) were also pursued and
suggested that transitions to alanine, cysteine, isoleucine,
methionine, proline, threonine, valine, tyrosine, and tryptophan
were significant in determining DC status (Table 3, right panel).Fig. 2. Amino acid distribution of uDCs and DCs. Graphical representation of frequ
along the vertical axis and the SNP amino acid is along the horizontal axis. Note that
squares. p values for substitutions occurring significantly more frequently in one S
frequently.Similar analyses were pursued by considering transitions
implicated in different kinase domains. The results suggested
that mutations at cysteine outside of functional domains
(p<0.0001), in NAI (p=0.0006), and PPI (p=0.0259), and in
receptor domains (p<0.0001), aspartic acid in PH domains
(p=0.0202), glycine in kinase domains (p=0.0004), methionine
outside of functional domains (p=0.0418) and within kinase
domains (p=0.414), arginine within PPI (p=0.0121) and kinase
(p=0.0097), glutamine (p=0.0006), tyrosine (p=0.0214), and
tryptophan (p=0.0174) within kinase domains were more likely
to be associated with disease, while mutations from isoleucine
(p<0.0001) in kinase domains, proline (p=0.0227) in receptors,
and glutamine (p=0.0056), serine (p=0.0239), threonine
(p=0.0237), and valine (p=0.0288) outside of functional
domains were less likely to be associated with disease.ency of amino acid substitutions for uDCs and DCs. The original amino acid is
many amino acid changes are not possible by a SNP and are displayed as blank
NP set than in the other are displayed within the set in which they occur more
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tryptophan (p=0.0138) outside of functional domains, to
cysteine (p=0.0106) and tyrosine (p=0.0264) in receptors,
and to tryptophan (p=0.0032) and proline (p=0.0004) within
the kinase domain were more likely to be associated with
disease, while mutations to alanine (p=0.0109) and valine
(p=0.0069) outside of functional domains, to glycine in PH
domains (p=0.0202), to asparginine in receptors (p=0.0446),
and to methionine in kinase domains (p<0.0001) were less
likely to be associated with disease.
Amino acid changes
A comparison of all DCs and uDCs with respect to their
distribution over amino acid changes demonstrated significant
differences (Fig. 2) based on a 146×2χ2 contingency table test,
p<0.0001. Two-tailed Fisher's exact tests were used to analyze
each change (with a sufficient number of DC and uDC SNPs) in
isolation. The p values of amino acid changes occurring at
significantly different rates in DCs and uDCs are displayed in
Fig. 2, where the p value is shown within the nscSNP set in
which it occurs more frequently. The results of a stepwiseTable 4
Amino acid subsitutions, stepwise logistic regression
Transition Estimate χ2 p value
A to D(1) 0.3738 2.1997 0.138
A to E(1) 1.1785 4.6139 0.0317
A to P(1) 0.3738 3.0068 0.0829
A to T(0) 0.4786 6.0387 0.014
A to V(0) 0.2461 1.9981 0.1575
C to F(1) 1.0669 10.8231 0.001
C to G(1) 0.7792 6.6517 0.0099
C to R(1) 1.1258 16.3763 0.0001
C to S(1) 0.9231 10.1027 0.0015
C to W(1) 1.1258 8.2416 0.0041
C to Y(1) 1.3643 25.8051 <.0001
D to A(1) 0.8319 3.9320 0.0474
D to E(0) 0.4786 3.0598 0.0803
D to G(1) 0.4573 4.8672 0.0274
D to Y(1) 1.1258 8.2416 0.0041
E to A(1) 0.9231 2.5484 0.1104
E to K(1) 0.4405 8.3195 0.0039
F to I(0) 3.7536 0.0879 0.7669
F to S(1) 0.7203 6.8269 0.009
F to V(1) 0.8319 3.9320 0.0474
G to A(0) 0.7249 1.8847 0.1698
G to D(1) 0.5049 5.6363 0.0176
G to E(1) 0.4741 4.3635 0.0367
G to R(1) 0.4471 7.8297 0.0051
G to V(1) 0.4508 2.5929 0.1073
I to K(1) 4.5088 0.0416 0.8383
I to N(1) 1.0669 3.6308 0.0567
I to R(1) 4.5088 0.0208 0.8853
I to V(0) 0.6168 5.2739 0.0216
K to E(1) 0.2556 2.1185 0.1455
L to M(0) 0.9087 3.0558 0.0804
L to P(1) 0.7348 23.6279 <.0001
L to R(1) 1.1785 9.1971 0.0024
L to V(0) 0.6660 3.1315 0.0768
(1) DC associated, (0) uDC associated.logistic regression analysis (the p value to enter the model was
set at 0.15, and the p value to exit the model was set at 0.1)
identified many more amino acid substitutions which were
significant predictors of DC status (Table 4).
Nucleotide analysis
We also considered an analysis involving codon positions of
the nscSNPs. We found that there was no significant difference
in the codon positions of nscSNPs in DCs and uDCs (χ2,
p=0.0704). However, we did find significant differences
between the A to G (p=0.0414), A to T (p=0.0114), C to G
(p=0.0027), T to C (p=0.0004), and T to G (p=0.101)
nucleotide substitution rates in DCs and uDCs (two-tailed
Fisher's exact test) with enrichment of T to C and T to G
substitutions in DCs and A to G, A to T, and C to G substitutions
in uDCs when we analyzed that nucleotide substitution alone.
All other transitions and transversions had no significant
differences. When we confined attention to specific positions
with a codon using two-tailed Fisher's exact tests we found that
substitutions from A to G (p=0.0487), C to A (p=0.0187, C to
G (p=0.0007), and G to A (p=0.0128) at the first position of theTransition Estimate χ2 p value
L to W(1) 4.5088 0.0208 0.8853
M to I(1) 0.3738 2.4698 0.1161
M to K(1) 4.5088 0.0416 0.8383
M to R(1) 1.2696 5.5078 0.0189
M to T(1) 0.6536 8.5239 0.0035
P to A(0) 0.8687 2.7761 0.0957
P to S(1) 0.2622 2.3598 0.1245
Q to H(0) 0.6660 3.1315 0.0768
Q to K(0) 0.8687 2.7761 0.0957
Q to R(0) 0.6963 3.4455 0.0634
R to C(1) 0.4508 9.9879 0.0016
R to H(1) 0.2866 3.5849 0.0583
R to P(1) 0.8642 12.8103 0.0003
R to Q(1) 0.3738 8.1533 0.0043
R to S(1) 0.5330 5.1666 0.023
R to W(1) 0.7871 23.2258 <.0001
S to N(0) 0.8687 5.5318 0.0187
S to T(0) 3.7536 0.1758 0.675
S to W(1) 4.5088 0.0208 0.8853
S to Y(1) 0.6292 2.9467 0.0861
T to P(1) 0.4508 2.5929 0.1073
T to S(0) 0.6963 3.4455 0.0634
V to D(1) 1.0669 3.6308 0.0567
V to F(1) 0.7203 4.1179 0.0424
V to I(0) 0.4721 5.1474 0.0233
V to L(0) 0.3783 1.8490 0.1739
W to C(1) 1.5250 8.4265 0.0037
W to L(1) 4.5088 0.0416 0.8383
W to R(1) 0.7203 4.1179 0.0424
W to S(1) 4.5088 0.0832 0.7729
Y to C(1) 1.0487 23.9205 <.0001
Y to D(1) 1.0669 7.2384 0.0071
Y to H(1) 0.5765 3.1599 0.0755
Y to S(1) 1.1785 4.6139 0.0317
Table 5
Group and domain interactions, stepwise regression
Interaction terms Estimate χ2 p value
PMI(0) 0.4871 2.6168 0.1057
GPI(0) 3.6946 0.1106 0.7395
AGC(0)*FN(0) 3.6585 0.0409 0.8397
AGC(0)*CB(1) 2.5021 0.0192 0.8899
AT(0)*PH(1) −0.1920 0.0001 0.994
AT(0)*NAI(1) −4.2567 0.0963 0.7564
CAMK(0)*kin(1) 0.3502 9.9484 0.0016
CAMK(0)*PPI(0) −0.7249 10.2761 0.0013
CAMK(0)*CB(1) 2.8142 0.0242 0.8763
RGC(1)*kin(1) 0.4392 5.0384 0.0248
RGC(1)*Recp(1) 0.4416 6.5248 0.0106
TK(1)*kin(1) −0.0298 0.1531 0.6956
TK(1)*PH(1) −2.4479 0.0187 0.8914
TK(1)*PPI(0) 0.2571 2.3770 0.1231
TKL(1)*kin(1) −0.2859 6.4168 0.0113
TKL(1)*Recp(1) −0.8007 18.8259 <.0001
OPK(0)*PPI(0) −0.5988 7.1560 0.0075
Kin, kinase; Recp; receptor; (1), True; (0), False.
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(p=0.0004), T to C (p=0.00032), and T to G (p=0.0036) at the
first position of the codon were significantly enriched in DCs.
At the second position C to G (p=0.0405) and C to T
(p=0.0001) substitutions were significantly enriched in uDCs,
while T to G (p=0.0076) is significantly enriched in DCs. This
correlates well with the result that nscSNPs involving cysteine,
tyrosine, and tryptophan are greatly enriched (380–535%) inFig. 3. nscSNP tree diagram. Tree diagram showing the 18 best partitions for splittin
displayed. Note that (1)= true and (0)= false.DCs and corresponds well to nucleotide substitutions that will
result in the largest change in the physiochemical properties of
the corresponding amino acids.
Integrated analysis
We considered a set of analyses designed to globally
determine whether certain kinase groups, domains, amino acid
transitions, and their possible interactions (denoted by an asterix
in the text), could differentiate DC and uDCs. We used multiple
binary logistic regressions for these analyses. We first con-
sidered an analysis focusing on just kinase groups and domains.
The results of this analysis suggested that interactions involving
kinase*TK, receptor*TKL, kinase*RGC, PH*Atypical, CB*
CAMK, kinase*AGC, PPI*Other PK, receptor*TK, kinase*
Other PK, kinase*Atypical, and NAI*Atypical were predictive
of DC status (Table 5). Other interactions are also presented in
Table 4.
We then considered two analyses involving groups, domains,
and amino acid transitions. The first analysis considered groups,
domains, and the amino acid associated with the mutant allele.
The second analysis considered groups, domains, and the amino
acid associated with the wild-type allele. The results of these
regressions are presented in Supplemental Table 1. To
graphically represent the partitioning of DCs and uDCs by
domain, group, and amino acid transition properties, we
provided a tree diagram showing the 18 best splits that separate
the nscSNPs by disease status (Fig. 3). Fig. 3 plainly shows thatg DC from uDC. The percentage of total SNPs left remaining after each split is
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clearly have a greater frequency of DCs, as seen in our statistical
analyses.
Conservation vs structural analysis
We considered the information gain in the use of structural
information over conservation information since it is clear that
DCs occupy more strongly conserved positions than uDCs.
However, when the kinase catalytic domains are aligned, 50.0%
of DCs occur at positions where only one or two other DCs
occur (data not shown). Therefore, while DCs certainly occur at
highly conserved functional positions and within conserved
motifs, a majority occur at positions of structural importance
which are not conserved for specific functional roles. This is
further indicated by the fact that RGC kinases are enriched for
DCs in its inactive kinase catalytic domain. The importance of
domain and amino acid information can be demonstrated by
attempting to classify the uDCs and DCs using solely subPSEC
conservation scores or those scores in addition to amino acid,
group, and domain information. Using a variety of classifiers in
the Weka data mining software package [18], the performance
of classifiers was improved significantly with the addition of
domain, group, and amino acid information. For example, the
DecisionTable classifier using 10-fold cross-validation demon-
strated an increase in sensitivity from 0.536 to 0.747 while
maintaining the specificity from 0.867 to 0.870. Additionally, the
Matthews correlation coefficient increased from 0.438 to 0.620
with the addition of domain, group, and amino acid information.
Comparison with mouse kinase nscSNPs
We considered an analysis comparing the frequency with
which human uDCs and mouse nscSNPs both originate and
result in a change to specific amino acids. We found through
two-tailed Fisher's exact tests focusing on specific amino acids
that the nscSNPs originated and resulted from that transitions
from alanine (p=0.0031), from threonine (p=0.0004), from
valine (p=0.0362), to alanine (p<0.0001), to threonine
(p=0.0239), and to valine (p=0.0130) occurred significantly
more often in mice while transitions from cysteine (p=0.0400),
from glutamic acid (p=0.0047), from arginine (p<0.0001), to
cysteine (p=0.0421), to lysine (p=0.0022), to proline
(p=0.0013), to glutamine (p=0.0087), and to tryptophan
(p<0.0001) occurred significantly more often in humans.
Discussion
The biased distribution of disease-causing nscSNPs reported
herein more than likely reflects the functional roles of particular
domains and the structural significance of specific amino acids.
The clustering of DCs within the kinase catalytic domain is
consistent with phylogenetic data showing a highly conserved
catalytic core [19]. This implies that the catalytic core has a low
tolerance for amino acid changes. In addition, many develop-
mental diseases and cancers result from dysfunctional growth
factor signaling, for which tyrosine kinases play a fundamentalrole. Amino acid alterations in extracellular growth factor
receptor domains may cause the binding affinity for growth
factors to change, and even a modest change in growth factor
binding affinities may induce tumorigenesis or other growth and
developmental anomalies [20]. Thus, a clustering of DCs in
receptor domains could have been anticipated. Also, pleckstrin
homology domains generally act as membrane targeting units
and thus are important for the proper localization of kinases,
although they are known to play other roles, such as mediating
protein–protein interactions [21]. This suggests that a start to
discovering functional SNPs within the uDC mutations would
be to consider nscSNPs within receptor structures or the kinase
catalytic domain and especially the catalytic domain of tyrosine
kinases.
Interestingly, the kinase groups enriched in the DC set
relative to the uDC set, TKs, RGCs, and TKLs, are very closely
related groups, appearing adjacent to one another on the
phylogenetic tree [1]. We believe that the lack of correlation
shown between the experimentally induced mutations within
kinase groups and their occurance in disease demonstrates that
this observation is not an artifact of biased research and
demonstrates a real increased propensity for disease causing
mutations in specific kinase groups. It is possible that these
kinases have evolved similar structures that are more sensitive
to perturbations, as sequence and structure similarity corre-
spond to similarities in both molecular and biological function
[22]. Alternatively, these kinases may be involved in pathways
with limited functional redundancy compared to other kinase
groups. Thus, mutations within kinases with limited redundancy
could cause overt monogenic diseases while kinases participat-
ing in pathways with redundancy will not easily be detected as
disease-causing, even when they contain similar structural
mutations. We also cannot formally exclude the possibility that
other kinases may play fundamental roles in human develop-
ment, such that functional mutations in these are rarely detected
as they tend to result in embryonic lethality.
The amino acids associated with DC nscSNPs in kinases
show general agreement with previous predictions concerning
the probability that an amino acid substitution will cause disease
on a genomewide scale [23]. Mutations involving cysteine,
tyrosine, tryptophan, and arginine have been shown to be
associated with human disease on a genomewide scale.
Methionine, on the other hand, is not strongly associated with
disease on a genomewide scale. Cysteine, tryptophan, and
tyrosine are among the most evolutionarily conserved residues
due to their importance in determining protein structure and
stability [24,25]. Thus, it is expected that mutations at these
residues are likely to cause disease and that mutations resulting
in a change to one of these residues are likely to adversely affect
protein structure. The high frequency and mutability, due to 5′-
CpG dinucleotides in arginine codons, of arginine in human
proteins and the fact that the relevant codons in these proteins
mutate to chemically dissimilar residues, including cysteine and
tryptophan, are probable explanations for their roles in causing
diseases.
Alanine, valine, serine, threonine, and isoleucine are weakly
evolutionarily conserved and have little impact on protein
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surprising. Glutamine's tendency to mutate to chemically
similar residues, with the exception of proline, may explain
its association with uDCs.
Glycine was found to be disease causing only within the
catalytic domain. Thus, while glycine plays an important
structural role in the turns of α-helices, it is likely that a large
proportion of disease-causing mutations in kinases occur at
conserved functional sites such as the Gly-X-Gly-X-X-Gly
motif of the ATP-binding loop. In fact, 10 of 46 (21.74%) of
glycine mutations in the catalytic domain occur at these
positions.
The same argument applies to aspartic acid. The prevalence
of mutations at aspartic acid in the kinase catalytic domain
suggests a kinase-specific role in disease etiology. There are two
conserved aspartic acids in the catalytic domain: one is in the
activation loop that is important for the catalytic activity of the
enzyme and for which mutations cause a number of diseases
[26–29]. In addition, aspartic acid's acidic side chain may be
important structurally due to its hydrogen bonding character-
istics and may be important for modulating regulatory
interactions between different subdomains of kinases. Indeed,
this appears to be the case as aspartic acid mutations are also
strongly associated with disease in pleckstrin homology
domains.
Methionine tends to produce disease when it is mutated in
kinase domains and outside of the catalytic domain. Within the
entire human genome methionine is not strongly associated with
human disease. This suggests unique functional roles for
methionine within kinase catalytic domains. A possible
explanation is that methionine tends to occur before the A-P-E
motif in the hydrophobic binding pocket. Mutations to charged
or polar residues such as lysine, arginine, or threonine may
reduce its substrate binding affinity [30,31]. However, when a
mutation results in methionine, it can result from mutations at
isoleucine, valine, and leucine, which are structurally less
important than other amino acids and are physiochemically
similar to methionine.
Proline is an interesting case since mutations that transition
from proline generally do not cause disease but mutations
transitioning to proline inside kinase domains do tend to cause
disease. This suggests that prolines are rare within turns of the
five-strandedβ-sheet of the kinase domain, or mutations at those
positions result in lethality. Mutations that result in a proline
within the kinase domain will alter its structure significantly
enough to cause functional defects and in particular may cause
breaks within helices, while those outside of functional domains
may generally occur in loops where the three-dimensional (3D)
structure is less important than that within functional domains.
However, it is also clear from our regression analyses that
different groups or domains show different patterns of DCs
depending on the amino acid that is mutated or the amino acid
arising from mutation. This may be a result of the different
biological activities executed by the specific domains and the
chemical properties required to facilitate those functions. For
example, membrane attachment and carbohydrate binding
would require extremely different chemical properties withregard to hydrogen bonding and hydrophobic interactions. It is
also possible that the dissimilar propensities of specific amino
acids, within different groups and domains, to cause disease are
a result of the differential amino acid compositions of conserved
motifs. However, this bias is a reflection of the chemical process
in which each domain is involved.
A number of methods for predicting deleterious mutations,
for example SIFT [32], rely exclusively upon DNA and amino
acid sequence conservation. However, it has been observed
recently [33] that residues evolving under strong selective
pressures are much more highly mutated than strictly conserved
residues. These residues are noted to be of structural relevance
and are significantly associated with disease. Other prediction
methods, such as PMUT [34], attempt to leverage generalized
structural information in combination with conservation
information when performing predictions or rely upon high-
quality 3D protein structures [35]. In light of the unique
spectrum of amino acid mutations within kinases and our
comparison of conservation and structural information in
predicting disease causing status, it is clear that mutational
analysis from whole-genome approaches and/or kinase-specific
conservation studies will not be sufficient to differentiate
functional uDCs from neutral uDCs with a high degree of
accuracy. Consideration of the functional characteristics of each
subdomain will be necessary before an increased level of
disease predictive accuracy is possible. We also acknowledge
the possibility that other data analysis techniques, such as neural
networks, support vector machines, and related discrimination
methods [36], may uncover more subtle associations involving
features of kinases that increase DC mutation status probability.
By comparison of mouse and human uDCs it appears that
mouse uDCs are enriched in those amino acid transitions that
were found to be associated with human uDC status and appear
to contain significantly fewer of those amino acid transitions
associated with human DC status. The implications of this are
unclear. Mouse and human kinases could simply operate under
different restrictions, or it could be that deleterious mutations
may have been more strongly selected against in the mouse
population. This may suggest that there are indeed a number of
deleterious functional SNPs within the human uDC set
exhibiting characteristics that have been selected against and
eliminated from mouse populations.
A number of human diseases are caused by SNPs [10].
However, the clear partitioning of DCs within specific domains
andwith different amino acidmutational spectrums suggests that
the majority of the uDCs are not likely to alter function
drastically. However, it is possible that common nscSNPs may
contain the mutations, or combination of mutations, underlying
common disease [37–39]. It is clear that complex or common
disease will present a different amino acid or domain distribution
[40], the similarity of which to overt, monogenic Mendelian
diseases of the type considered here is yet to be determined. In
this light, there are some caveats or limitations of our analyses
that go beyond identification of the more subtle effects that some
nscSNPs will have on complex disease susceptibility. First,
our analysis considered SNPs and diseases documented in the
public domain and as such provide only a snapshot of all
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of the DC nscSNPs that we studied were identified within the
same gene and contributed to similar diseases. Thus, without
accommodating the central role that certain genes may play in
particular disease-relevant processes, we cannot necessarily
claim that our analysis is based on an independent set of DC
nscSNPs.
Despite these limitations, the elucidation of the functional
consequences of uDCs with profiles similar to those of DCs as
described here would provide an interesting starting point for
exploration of nscSNPs involved in non-Mendelian, complex
disease. To accurately differentiate between functional and
neutral SNPs within the uDCs, further analysis will be
necessary. It is also possible that characterization of the
properties of precancerous somatic mutations may be accom-
plished in a similar manner, assuming that they have
characteristics similar to those of DCs. Theoretically, such an
extension should be possible since both the inherited disease
susceptibility and the DNA changes in somatic cells associated
with cancers can result from altered protein function.
Materials and methods
Kinase protein and DNA sequences were obtained from Kinbase. uDCs
were determined as follows: Ensembl Gene IDs were determined by BLAST
search using the Ensembl website (http://www.ensembl.org/Homo_sapiens/
blastview). To collect uDCs (Supplemental Table 2) Ensembl Gene IDs were
used to query PupaSNP using the PupaSNP website and dbSNP using the
Ensembl data mining tool, Biomart (http://www.ensembl.org/Homo_sapiens/
martview). For genes that produced no results, Entrez Gene IDs, UniProt IDs,
GenBank IDs, or HGNC approved symbols were used as the query. These IDs
were determined using a combination of Biomart, the Genecards database
(www.genecards.org), and the HUGO Gene Nomenclature Committee website
(http://www.gene.ucl.ac.uk/nomenclature/). A number of genes with no
appropriate Ensembl Gene ID were directly queried in dbSNP. Mouse uDCs
were determined by obtaining the predetermined ensemble IDs for mouse
homologs of human kinases and using those as the query in Biomart.
DCs (Supplemental Table 3) were determined as follows: Entrez Gene IDs
were used to query OMIM, returning OMIM IDs that were used as a query in the
OMIM website to determine DCs. KinMutBase DCs were assigned to kinases
by name with the Genecards database being used to determine alternate names.
The Human Gene Mutation Database was queried by HGNC IDs. All deletions,
insertions, and nonsense mutations were not considered in our analyses.
All nscSNPs were assigned to positions in Kinbase protein sequence using
flanking sequences in the Ensembl and Entrez Gene sequences because of
higher confidence in Kinbase sequences versus other publicly available
sequences. Corresponding positions in DNA sequences were determined
using a combination of flanking sequences given in dbSNP data and Genewise
[41] (http://www.ebi.ac.uk/Wise2/). For situations in which protein and DNA
sequences did not agree, the DNA sequence was assumed to correspond to the
major allele (43 cases in uDCs). SNPs were discarded in the rare case that
nscSNPs had no match in either protein or DNA sequences or when the SNP
could not have resulted from a single mutation as determined by the
corresponding codon. In 2 cases the amino acid in the Kinbase sequence did
not match either major or minor alleles from SNP information while all flanking
sequences matched. It was noticed that the amino acid appearing in the Kinbase
sequence could have been a result of a SNP and it was added to the list as a novel
SNP. Similar complications did not occur in the DCs list. The accuracy of amino
acid positions was validated computationally. Once the major codon was
determined, nucleotide transitions were elucidated with a combination of
computational methods, to the extent that it was possible, and SNP information
was provided by dbSNP and Ensembl data.
Functional domain structures were determined by using InterProScan using
mainly Prosite and Pfam predictions. Domains were then classified into moregeneral categories depending on their function (Supplemental materials). IG-like
domains occurring outside the cell membrane as determined by TMHMM
Server (http://www.cbs.dtu.dk/services/TMHMM/) in tyrosine kinase receptors
were grouped with other receptors. Placement of nscSNPs in functional domains
was then determined computationally.
SubPSEC scores were determined using the PANTHER database [40,42].
All statistical analyses were performed using JMP IN 5.1 (SAS Institute Inc.
Cary, NC, USA).
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